All News
Bimekizumab Efficacy in TNF-Refractory Psoriatic Arthritis
Bimekizumab, a selective inhibitor of interleukin (IL)-17F and IL-17, has shown superior efficacy and safety in a 16 week trial in patients with active psoriatic arthritis who previously failed therapy with tumour necrosis factor-α (TNFi) inhibitors.
Read Article
The Top 10 Research Priorities in Psoriatic Arthritis
A survey of 317 carers and clinicians focused on psoriatic arthritis has set an agenda of the top 10 research questions for psoriatic arthritis (PsA).
Read Article
Multi-ancestry analysis reveals novel genetic loci associated with Osteoarthritis
The first large multi-ancestry genetics study of osteoarthritis (OA) has found 10 novel OA-associated genetic loci, and results showed some of the OA-associated regions are robustly found in every population ancestry studied.
Read Article
GCA: What we feel and what we can't
Dr. David Liew ( @drdavidliew) discusses Abstracts 0483 and 0486 at #ACR22 Convergence.
https://t.co/Pobsb2anLa https://t.co/RQS4N3TqgK
Links:
Dr. John Cush RheumNow ( View Tweet)
Timely Fetal Screening Important in Positive Anti-Ro Antibody Pregnancies
Dr. Yusof ( @Yuz6Yusof) discusses Abstract 0957 presented at #ACR22.
https://t.co/yl4K7jZMGr https://t.co/6733AEhRyX
Links:
Dr. John Cush RheumNow ( View Tweet)
Imaging in PMR
One of the major limitations of PMR management is the lack of a gold standard investigation or biomarker of disease activity.
https://t.co/sZtgWKAtFv https://t.co/4H4tAY6CIZ
Links:
Dr. John Cush RheumNow ( View Tweet)
Why treatment of pre-RA isn't ready for prime time
The ACR Great Debate was on "To treat or not to treat in pre-RA?" and it was stressed that autoimmunity may start well before clinical symptoms occur.
https://t.co/A0dx3PFyiJ https://t.co/wqBuM8XD7M
Links:
Dr. John Cush RheumNow ( View Tweet)
Familial Mediterranean Fever mimics
Dr Baspinar et al. performed a large case-control study in Turkey to assess whether acute abdomen episodes which led to appendectomies could be misdiagnosed as appendicitis rather than FMF-associated serositis.#ACR22
https… https://t.co/fHgeoLjNOu
Dr. John Cush RheumNow ( View Tweet)
Hydroxychloroquine: Cumulative Doses and Thresholds
Dr. Sheila Reyes ( @RHEUMarampa) discusses Abstracts 0982 and 0344 at #ACR22 Convergence.
https://t.co/k33LUNnTmV https://t.co/AJSBdT4rJC
Links:
Dr. John Cush RheumNow ( View Tweet)
Spondyloarthritis: Novel Therapies, Diagnostic Dilemmas and Depression
Dr. Lianne Gensler ( @lianegensler discusses the following abstracts presented at #ACR22. Abstracts 1597, 1598, 1599 (treatment) and 1613, 1609 and 1614 (diagnosis and outcomes)
https://t.co/0wCxKyFM0u https://t.co/8vaZ1ZncjF
Links:
Dr. John Cush RheumNow ( View Tweet)
Comorbidities in Ankylosing Spondylitis
Dr. Akhil Sood ( @AkhilSoodMD) discusses Abstract 1609 at #ACR22 Convergence.
https://t.co/tX0gP3mYmW https://t.co/PYLpoczz08
Links:
Dr. John Cush RheumNow ( View Tweet)
Vaccines Work!
Dr. Eric Dein ( @ericdeinmd) and Dr. Caoilfhionn Connolly discuss abstracts 2275 & 0797 at #ACR22 Convergence.
https://t.co/xXcs5yQPSi https://t.co/1C4Cj9Ykei
Links:
Dr. John Cush RheumNow ( View Tweet)
Systematic review of MSK findings in patients with acute lymphoblastic leukemia finds 29 pts with peripheral arthritis (7), axial manifestations (17), and osteolytic lesions (21 pts) & Vertebral Fx (4) Hypercalcemia in 9 cases. https://t.co/DhCMMlMs7f https://t.co/HjjL4aF22a
Links:
Dr. John Cush RheumNow ( View Tweet)
Comparison of 227 Systemic Sclerosis pts w/ & without ILD shows SSc-ILD to have more muscle Dz [OR 2.55], LVDD [OR 2.36], PAH [OR 9.13], dcSSc [OR 2.86], PLR [OR 1.005], elevated KL-6 [OR 2.03], and anti-Scl-70 [OR 3.1]. https://t.co/Pzx9N5rPcF https://t.co/F8mBQ1u5iL
Links:
Dr. John Cush RheumNow ( View Tweet)
Fat and bone are never alone: osteoporotic fracture in RA
Dr. David Liew ( @drdavidliew) discusses Abstract 889 at #ACR22. Abstract 889: Serum Adipokines Predict Incident Osteoporotic Fracture in Patients with Rheumatoid Arthritis
https://t.co/jSFmOiQb6N https://t.co/JTXugoxofP
Links:
Dr. John Cush RheumNow ( View Tweet)
Gender Differences in axSpA
In abstract 1614, Dr. Poddubnyy presents the results of the PROOF study which assessed the probability of achieving inactive disease or low disease activity among males and females who were recently diagnosed with axSpA.
https://t.co/DL2TDgXJnG https://t.co/XSQxWWnQgD
Links:
Dr. John Cush RheumNow ( View Tweet)
Lupus Linked With Greater Risk of Cardiovascular Complications of Childbirth
Pregnant women with SLE were more prone to cardiovascular complications during delivery, and their risk seems to have increased over the past 15 years, according to data.
https://t.co/mRUOVrKbt2 https://t.co/m18DWxSV20
Links:
Dr. John Cush RheumNow ( View Tweet)
Retrospective study of US National Inpatient Sample data 2015-2019 looked at 60,360 gout admissions, roughly 1/4 had Arrhythmias (mostly older pts; AFib (88%), atr flutter (6.2%), VTach (3.2%). Gout-arrhythmia pts had more deaths (adj OR 2.06) https://t.co/L1WEsybI7h https://t.co/xwAfFVJOuk
Links:
Dr. John Cush RheumNow ( View Tweet)
In pts undergoing hip or knee arthroplasty for OA, aspirin (3.45%) compared with enoxaparin (1.82%) resulted in a significantly higher rate of symptomatic VTE within 90 days, defined as below- or above-knee DVT or pulmonary embolism https://t.co/7hgLbynNx6 https://t.co/HMc4UbMcdy
Links:
Dr. John Cush RheumNow ( View Tweet)
RA-ILD takes centre stage
Greg McDermott presented abstract 2248 on the prevalence and mortality of subpleural interstitial lung abnormalities (ILA) in RA and non-RA comparators.
https://t.co/zrg7IEhBfg https://t.co/dKACCzr4CZ
Links:
Dr. John Cush RheumNow ( View Tweet)
